Ernexa Therapeutics Inc.
Profit History
| Period | Revenue | Operating Income | Net Income |
|---|---|---|---|
| Jun 2010 | $6.2M | $-407.0K | $-457.0K |
| Sep 2010 | $6.5M | $155.0K | $124.0K |
| Mar 2011 | $6.0M | $-520.0K | $-559.0K |
| Jun 2011 | $6.1K | $-1.1M | $-984.0K |
| Sep 2011 | $5.9M | $-795.0K | $-837.0K |
| Dec 2011 | $6.1M | $-908.0K | $-1.0M |
| Mar 2012 | $6.1M | $-997.0K | $-1.0M |
| Jun 2012 | $6.0K | $-643.0K | $-633.0K |
| Sep 2012 | $6.1M | $99.0K | $54.0K |
| Dec 2012 | $5.9M | $479.0K | $629.0K |
| Mar 2013 | $6.1M | $-366.0K | $-369.0K |
| Jun 2013 | $5.5M | $-115.0K | $-99.0K |
| Sep 2013 | $5.5M | $-236.0K | $-234.0K |
| Mar 2014 | $6.4M | $-654.0K | $-649.0K |
| Jun 2014 | $6.9M | $-1.3M | $-1.3M |
| Sep 2014 | $6.0M | $-1.3M | $-1.3M |
| Mar 2015 | $5.7M | $-2.2M | $-2.3M |
| Jun 2015 | $6.2M | $-2.5M | $-2.6M |
| Sep 2015 | $6.1M | $-1.3M | $-1.3M |
| Mar 2016 | $5.5M | $-868.0K | $-1.0M |
| Jun 2016 | $5.4M | $-696.0K | $-850.0K |
| Sep 2016 | $5.4M | $-414.0K | $-573.0K |
| Mar 2017 | $5.2M | $-834.0K | $-90.0K |
| Jun 2017 | $5.5M | $-26.0K | $-164.0K |
| Sep 2017 | $5.2M | $-53.0K | $-184.0K |
| Mar 2018 | $5.8M | $-313.0K | $-409.0K |
| Jun 2018 | $5.7M | $-27.0K | $-124.0K |
| Sep 2018 | $6.0M | $370.0K | $222.0K |
| Mar 2019 | $4.8M | $-217.0K | $-313.0K |
| Jun 2019 | $5.2M | $-2.0K | $-90.0K |
| Sep 2019 | $4.6M | $-316.0K | $-351.0K |
| Mar 2020 | $2.4M | $-1.0M | $-1.0M |
| Jun 2020 | $754.0K | $-2.0M | $-2.0M |
| Sep 2020 | $1.5M | $-2.0M | $-2.0M |
| Mar 2021 | — | $-8.9M | $-18.5M |
| Jun 2021 | — | $-10.0M | $-10.1M |
| Sep 2021 | — | $-86.3M | $-86.0M |
| Mar 2022 | — | $-6.3M | $-9.4M |
| Jun 2022 | — | $-13.9M | $-3.4M |
| Sep 2022 | $0 | $-8.3M | $-7.3M |
| Mar 2023 | $0 | $-5.3M | $-5.4M |
| Jun 2023 | — | $-4.5M | $-4.5M |
| Sep 2023 | $51.0K | $-5.5M | $-5.6M |
| Mar 2024 | $47.0K | $-5.8M | $-6.6M |
| Jun 2024 | $47.0K | $-4.9M | $-5.5M |
| Sep 2024 | $487.0K | $-2.3M | $-26.6M |
| Mar 2025 | — | $-2.7M | $-8.2M |
| Jun 2025 | — | $-2.5M | $-3.1M |
| Sep 2025 | — | $-2.0M | $-1.2M |
| Mar 2026 | — | $-5.6M | $-5.5M |
| Jun 2026 | — | $-4.1M | $-4.0M |